Effects of spinally administered bifunctional nociceptin/orphanin FQ peptide receptor/μ-opioid receptor ligands in mouse models of neuropathic and inflammatory pain

DD Sukhtankar, NT Zaveri, SM Husbands… - Journal of Pharmacology …, 2013 - ASPET
Nociceptin/orphanin FQ peptide receptor (NOP) agonists produce antinociceptive effects in
animal models after spinal administration and potentiate μ-opioid receptor (MOP)-mediated …

[PDF][PDF] Effects of Spinally Administered Bifunctional Nociceptin/Orphanin FQ Peptide Receptor/m-Opioid Receptor Ligands in Mouse Models of Neuropathic and …

DD Sukhtankar, NT Zaveri… - THE JOURNAL OF …, 2013 - drive.google.com
Nociceptin/orphanin FQ peptide receptor (NOP) agonists produce antinociceptive effects in
animal models after spinal administration and potentiate m-opioid receptor (MOP)-mediated …

Effects of spinally administered bifunctional nociceptin/orphanin FQ peptide receptor/μ-opioid receptor ligands in mouse models of neuropathic and inflammatory pain

DD Sukhtankar, NT Zaveri… - Journal of …, 2013 - researchportal.bath.ac.uk
Nociceptin/orphanin FQ peptide receptor (NOP) agonists produce antinociceptive effects in
animal models after spinal administration and potentiate μ-opioid receptor (MOP)-mediated …

Effects of spinally administered bifunctional nociceptin/orphanin FQ peptide receptor/μ-opioid receptor ligands in mouse models of neuropathic and inflammatory pain.

DD Sukhtankar, NT Zaveri, SM Husbands… - The Journal of …, 2013 - europepmc.org
Nociceptin/orphanin FQ peptide receptor (NOP) agonists produce antinociceptive effects in
animal models after spinal administration and potentiate μ-opioid receptor (MOP)-mediated …

Effects of spinally administered bifunctional nociceptin/orphanin FQ peptide receptor/μ-opioid receptor ligands in mouse models of neuropathic and inflammatory pain

DD Sukhtankar, NT Zaveri… - The Journal of …, 2013 - pubmed.ncbi.nlm.nih.gov
Nociceptin/orphanin FQ peptide receptor (NOP) agonists produce antinociceptive effects in
animal models after spinal administration and potentiate μ-opioid receptor (MOP)-mediated …

[HTML][HTML] Effects of Spinally Administered Bifunctional Nociceptin/Orphanin FQ Peptide Receptor/μ-Opioid Receptor Ligands in Mouse Models of Neuropathic and …

DD Sukhtankar, NT Zaveri, SM Husbands… - The Journal of …, 2013 - ncbi.nlm.nih.gov
Nociceptin/orphanin FQ peptide receptor (NOP) agonists produce antinociceptive effects in
animal models after spinal administration and potentiate μ-opioid receptor (MOP)-mediated …

[引用][C] Effects of Spinally Administered Bifunctional Nociceptin/Orphanin FQ Peptide Receptor/μ-Opioid Receptor Ligands in Mouse Models of Neuropathic and …

DD Sukhtankar, NT Zaveri, SM Husbands… - Journal of Pharmacology …, 2013 - cir.nii.ac.jp
Effects of Spinally Administered Bifunctional Nociceptin/Orphanin FQ Peptide Receptor/μ-Opioid
Receptor Ligands in Mouse Models of Neuropathic and Inflammatory Pain | CiNii Research …

[PDF][PDF] Effects of Spinally Administered Bifunctional Nociceptin/Orphanin FQ Peptide Receptor/m-Opioid Receptor Ligands in Mouse Models of Neuropathic and …

DD Sukhtankar, NT Zaveri… - THE JOURNAL OF …, 2013 - researchgate.net
Nociceptin/orphanin FQ peptide receptor (NOP) agonists produce antinociceptive effects in
animal models after spinal administration and potentiate m-opioid receptor (MOP)-mediated …

[PDF][PDF] Effects of Spinally Administered Bifunctional Nociceptin/Orphanin FQ Peptide Receptor/m-Opioid Receptor Ligands in Mouse Models of Neuropathic and …

DD Sukhtankar, NT Zaveri, SM Husbands… - THE JOURNAL OF …, 2013 - academia.edu
Nociceptin/orphanin FQ peptide receptor (NOP) agonists produce antinociceptive effects in
animal models after spinal administration and potentiate m-opioid receptor (MOP)-mediated …

Effects of spinally administered bifunctional nociceptin/orphanin FQ peptide receptor/μ-opioid receptor ligands in mouse models of neuropathic and inflammatory pain.

DD Sukhtankar, NT Zaveri, SM Husbands… - The Journal of …, 2013 - europepmc.org
Nociceptin/orphanin FQ peptide receptor (NOP) agonists produce antinociceptive effects in
animal models after spinal administration and potentiate μ-opioid receptor (MOP)-mediated …